Titre : Enzymes de réparation de l'ADN

Enzymes de réparation de l'ADN : Questions médicales fréquentes

Termes MeSH sélectionnés :

Hazard Analysis and Critical Control Points
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Enzymes de réparation de l'ADN : Questions médicales les plus fréquentes", "headline": "Enzymes de réparation de l'ADN : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Enzymes de réparation de l'ADN : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-06", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Enzymes de réparation de l'ADN" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Enzymes", "url": "https://questionsmedicales.fr/mesh/D004798", "about": { "@type": "MedicalCondition", "name": "Enzymes", "code": { "@type": "MedicalCode", "code": "D004798", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Uracil-DNA glycosidase", "alternateName": "Uracil-DNA Glycosidase", "url": "https://questionsmedicales.fr/mesh/D051981", "about": { "@type": "MedicalCondition", "name": "Uracil-DNA glycosidase", "code": { "@type": "MedicalCode", "code": "D051981", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.074.249.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Enzymes de réparation de l'ADN", "alternateName": "DNA Repair Enzymes", "code": { "@type": "MedicalCode", "code": "D045643", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Olga I Lavrik", "url": "https://questionsmedicales.fr/author/Olga%20I%20Lavrik", "affiliation": { "@type": "Organization", "name": "Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia." } }, { "@type": "Person", "name": "Alexandra L Zakharenko", "url": "https://questionsmedicales.fr/author/Alexandra%20L%20Zakharenko", "affiliation": { "@type": "Organization", "name": "Novosibirsk Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 8, Akademika Lavrentieva Ave., Novosibirsk 630090, Russia." } }, { "@type": "Person", "name": "Nariman F Salakhutdinov", "url": "https://questionsmedicales.fr/author/Nariman%20F%20Salakhutdinov", "affiliation": { "@type": "Organization", "name": "N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., Novosibirsk 630090, Russia." } }, { "@type": "Person", "name": "Konstantin P Volcho", "url": "https://questionsmedicales.fr/author/Konstantin%20P%20Volcho", "affiliation": { "@type": "Organization", "name": "N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia." } }, { "@type": "Person", "name": "Olga A Luzina", "url": "https://questionsmedicales.fr/author/Olga%20A%20Luzina", "affiliation": { "@type": "Organization", "name": "N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., Novosibirsk 630090, Russia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Hot weather hazard analysis over India.", "datePublished": "2022-11-17", "url": "https://questionsmedicales.fr/article/36396755", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-24065-0" } }, { "@type": "ScholarlyArticle", "name": "Tripartite evolutionary game and simulation analysis of agricultural non-point source pollution control.", "datePublished": "2024-06-28", "url": "https://questionsmedicales.fr/article/38941318", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0305191" } }, { "@type": "ScholarlyArticle", "name": "Surrogacy analysis of intermediate end-points for overall survival in randomized controlled trials of rhabdomyosarcoma.", "datePublished": "2022-11-12", "url": "https://questionsmedicales.fr/article/36371419", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-23944-w" } }, { "@type": "ScholarlyArticle", "name": "Acrolein: formation, health hazards and its controlling by dietary polyphenols.", "datePublished": "2023-05-19", "url": "https://questionsmedicales.fr/article/37203991", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/10408398.2023.2214625" } }, { "@type": "ScholarlyArticle", "name": "Assessing wineries' performance in managing critical control points for arsenic, lead, and cadmium contamination risk in the wine-making industry: A survey-based analysis utilizing performance indicators as a results tool.", "datePublished": "2023-12-05", "url": "https://questionsmedicales.fr/article/38163151", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.heliyon.2023.e22962" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Enzymes de réparation de l'ADN", "item": "https://questionsmedicales.fr/mesh/D045643" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Enzymes de réparation de l'ADN - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Enzymes de réparation de l'ADN", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Enzymes de réparation de l'ADN", "description": "Comment diagnostiquer une déficience en enzymes de réparation de l'ADN ?\nQuels tests sont utilisés pour évaluer la réparation de l'ADN ?\nLes biopsies peuvent-elles aider au diagnostic ?\nQuels marqueurs biologiques indiquent des problèmes de réparation ?\nLes antécédents familiaux sont-ils pertinents pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D045643?mesh_terms=Hazard+Analysis+and+Critical+Control+Points&page=7#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Enzymes de réparation de l'ADN", "description": "Quels symptômes indiquent une défaillance des enzymes de réparation ?\nLa fatigue est-elle un symptôme associé ?\nDes infections fréquentes peuvent-elles être un signe ?\nLes troubles neurologiques sont-ils liés à ces enzymes ?\nDes anomalies de la peau peuvent-elles survenir ?", "url": "https://questionsmedicales.fr/mesh/D045643?mesh_terms=Hazard+Analysis+and+Critical+Control+Points&page=7#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Enzymes de réparation de l'ADN", "description": "Comment prévenir les dommages à l'ADN ?\nLe tabagisme augmente-t-il les risques ?\nL'exercice physique aide-t-il à la prévention ?\nLes examens réguliers sont-ils importants ?\nUne bonne hydratation joue-t-elle un rôle ?", "url": "https://questionsmedicales.fr/mesh/D045643?mesh_terms=Hazard+Analysis+and+Critical+Control+Points&page=7#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Enzymes de réparation de l'ADN", "description": "Quels traitements existent pour les déficiences enzymatiques ?\nLa supplémentation en antioxydants est-elle bénéfique ?\nLes thérapies immunologiques sont-elles efficaces ?\nLa chimiothérapie est-elle utilisée dans ces cas ?\nDes traitements préventifs existent-ils ?", "url": "https://questionsmedicales.fr/mesh/D045643?mesh_terms=Hazard+Analysis+and+Critical+Control+Points&page=7#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Enzymes de réparation de l'ADN", "description": "Quelles complications peuvent survenir avec des déficiences ?\nLes maladies cardiovasculaires sont-elles un risque ?\nDes troubles de la reproduction peuvent-ils se développer ?\nLes troubles métaboliques sont-ils possibles ?\nLes infections opportunistes sont-elles un risque ?", "url": "https://questionsmedicales.fr/mesh/D045643?mesh_terms=Hazard+Analysis+and+Critical+Control+Points&page=7#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Enzymes de réparation de l'ADN", "description": "Quels facteurs génétiques influencent la réparation de l'ADN ?\nL'exposition aux produits chimiques est-elle un facteur ?\nLe vieillissement est-il un facteur de risque ?\nLe stress oxydatif joue-t-il un rôle ?\nLes infections virales peuvent-elles affecter la réparation ?", "url": "https://questionsmedicales.fr/mesh/D045643?mesh_terms=Hazard+Analysis+and+Critical+Control+Points&page=7#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en enzymes de réparation de l'ADN ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses cellulaires peuvent révéler des anomalies." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la réparation de l'ADN ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de comète et les tests de mutation sont couramment utilisés." } }, { "@type": "Question", "name": "Les biopsies peuvent-elles aider au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les biopsies peuvent montrer des anomalies dans la réparation de l'ADN." } }, { "@type": "Question", "name": "Quels marqueurs biologiques indiquent des problèmes de réparation ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de marqueurs de stress oxydatif peuvent indiquer des problèmes." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils pertinents pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancers peuvent indiquer des déficiences héréditaires." } }, { "@type": "Question", "name": "Quels symptômes indiquent une défaillance des enzymes de réparation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes incluent des cancers fréquents, des anomalies cutanées et des vieillissements prématurés." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme associé ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue peut résulter d'une accumulation de dommages à l'ADN." } }, { "@type": "Question", "name": "Des infections fréquentes peuvent-elles être un signe ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une réparation défectueuse de l'ADN peut affaiblir le système immunitaire." } }, { "@type": "Question", "name": "Les troubles neurologiques sont-ils liés à ces enzymes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Certaines déficiences peuvent entraîner des troubles neurologiques et cognitifs." } }, { "@type": "Question", "name": "Des anomalies de la peau peuvent-elles survenir ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des lésions cutanées et des cancers de la peau sont fréquents." } }, { "@type": "Question", "name": "Comment prévenir les dommages à l'ADN ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les radiations, les toxines et adopter une alimentation riche en antioxydants." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il les risques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque majeur pour les dommages à l'ADN." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la réparation de l'ADN et la santé cellulaire." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils importants ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies." } }, { "@type": "Question", "name": "Une bonne hydratation joue-t-elle un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hydratation est essentielle pour le bon fonctionnement cellulaire." } }, { "@type": "Question", "name": "Quels traitements existent pour les déficiences enzymatiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie génique et des médicaments ciblés." } }, { "@type": "Question", "name": "La supplémentation en antioxydants est-elle bénéfique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antioxydants peuvent aider à réduire les dommages à l'ADN." } }, { "@type": "Question", "name": "Les thérapies immunologiques sont-elles efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent renforcer la réponse immunitaire contre les cellules endommagées." } }, { "@type": "Question", "name": "La chimiothérapie est-elle utilisée dans ces cas ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent utilisée pour traiter les cancers associés aux déficiences." } }, { "@type": "Question", "name": "Des traitements préventifs existent-ils ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des stratégies de dépistage précoce et des conseils génétiques sont disponibles." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des déficiences ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des cancers, des maladies auto-immunes et des troubles neurologiques." } }, { "@type": "Question", "name": "Les maladies cardiovasculaires sont-elles un risque ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dommages à l'ADN peuvent contribuer à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Des troubles de la reproduction peuvent-ils se développer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines déficiences peuvent affecter la fertilité et la reproduction." } }, { "@type": "Question", "name": "Les troubles métaboliques sont-ils possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans la réparation de l'ADN peuvent entraîner des troubles métaboliques." } }, { "@type": "Question", "name": "Les infections opportunistes sont-elles un risque ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un système immunitaire affaibli peut augmenter le risque d'infections opportunistes." } }, { "@type": "Question", "name": "Quels facteurs génétiques influencent la réparation de l'ADN ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des mutations dans des gènes spécifiques peuvent augmenter le risque de déficiences." } }, { "@type": "Question", "name": "L'exposition aux produits chimiques est-elle un facteur ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des agents chimiques peut endommager l'ADN et affecter la réparation." } }, { "@type": "Question", "name": "Le vieillissement est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement naturel peut réduire l'efficacité des enzymes de réparation." } }, { "@type": "Question", "name": "Le stress oxydatif joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un stress oxydatif accru peut endommager l'ADN et affecter la réparation." } }, { "@type": "Question", "name": "Les infections virales peuvent-elles affecter la réparation ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections virales peuvent perturber les mécanismes de réparation de l'ADN." } } ] } ] }

Sources (10000 au total)

Surrogacy analysis of intermediate end-points for overall survival in randomized controlled trials of rhabdomyosarcoma.

Treatment of malignant tumors, such as rhabdomyosarcoma (RMS), can improve overall survival (OS). It is time-consuming and expensive for patients to obtain benefits from randomized controlled trials (...

The effect of electrical stimulation in critical patients: a meta-analysis of randomized controlled trials.

While electrical stimulation has been demonstrated to improve medical research council (MRC) scores in critically ill patients, its effectiveness remains a subject of debate. This meta-analysis aimed ... A comprehensive search of major electronic databases, including PubMed, Cochrane Library, and Embase, was conducted from inception to June 15, 2024, to identify randomized controlled trials (RCTs) tha... A total of 23 RCTs, including 1798 patients, met the inclusion criteria. The findings demonstrated a significant benefit of electrical stimulation over usual care in enhancing global muscle strength, ... Electrical stimulation appears to be an effective intervention for improving MRC scores in critically ill patients. However, further research is warranted to explain the potential effects of electrica... https://www.crd.york.ac.uk/PROSPERO/#recordDetails....

Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

To determine the safety and efficacy of probiotics or synbiotics on morbidity and mortality in critically ill adults and children.... We searched MEDLINE, EMBASE, CENTRAL, and unpublished sources from inception to May 4, 2021.... We performed a systematic search for randomized controlled trials (RCTs) that compared enteral probiotics or synbiotics to placebo or no treatment in critically ill patients. We screened studies indep... Independent reviewers extracted data in duplicate. A random-effects model was used to pool data. We assessed the overall certainty of evidence for each outcome using the Grading Recommendations Assess... Sixty-five RCTs enrolled 8,483 patients. Probiotics may reduce ventilator-associated pneumonia (VAP) (relative risk [RR], 0.72; 95% CI, 0.59 to 0.89 and risk difference [RD], 6.9% reduction; 95% CI, 2... Low certainty RCT evidence suggests that probiotics or synbiotics during critical illness may reduce VAP, HAP, ICU and hospital LOS but probably have no effect on mortality....

A Patient-Level Meta-Analysis of Intensive Glucose Control in Critically Ill Adults.

Whether intensive glucose control reduces mortality in critically ill patients remains uncertain. Patient-level meta-analyses can provide more precise estimates of treatment effects than are currently... We pooled individual patient data from randomized trials investigating intensive glucose control in critically ill adults. The primary outcome was in-hospital mortality. Secondary outcomes included su... Of 38 eligible trials (n=29,537 participants), 20 (n=14,171 participants) provided individual patient data including in-hospital mortality status for 7059 and 7049 participants allocated to intensive ... Intensive glucose control was not associated with reduced mortality risk but increased the risk of severe hypoglycemia. We did not identify a subgroup of patients in whom intensive glucose control was...

Accuracy of Point-of-Care Blood Glucometers in Neonates and Critically Ill Adults.

Inpatient glycemic management has become a common issue because of the increasing number of hospitalized patients with hyperglycemia. Point-of-care devices can enable timely inpatient glucose monitori... This cross-sectional study was conducted at a medical center in central Taiwan and enrolled patients admitted to the neonatal intensive care unit, sick child room, or respiratory intensive care unit b... Overall, 114 neonates (mean age, 4.2 days [range, 0-28 days]; 65 boys [57.0%]) and 106 hospitalized critically ill adults (mean age, 68.2 years [range, 27-94 years]; 72 men [67.9%]) were enrolled in t... Both glucose management systems met the accuracy criteria for venous blood from neonates and arterial blood from critically ill adults. Thus, the use of these 2 point-of-care devices in inpatient sett...